Drug safety signals in breastfeeding: Bridging evidence from European and US pharmacovigilance systems

Documenti analoghi

• Evaluation of the effect of CYP2D6 and OCT1 polymorphisms on the pharmacokinetics of tramadol: Implications for clinical safety and dose rationale in paediatric chronic pain
  di: Paul Healy, et al.
  Pubblicazione: (2024)
• From cradle to cane—(Dis)similarities between paediatric and geriatric clinical pharmacology: A commentary arising from the 2024 International Union of Basic and Clinical Pharmacology (IUPHAR) World Smart Medication Day
  di: Karel Allegaert, et al.
  Pubblicazione: (2025)
• Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance
  di: Ignatios Ioakeim‐Skoufa, et al.
  Pubblicazione: (2025)
• The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System
  di: Jianxing Zhou, et al.
  Pubblicazione: (2024)
• Innovations in pharmacovigilance studies of medicines in older people
  di: Lisa M. Kalisch Ellett, et al.
  Pubblicazione: (2024)